| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3376 |
| Trial ID | NCT05779930 |
| Disease | B-Cell Leukemia | B-Cell Lymphoma | Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL |
| Year | 2023 |
| Country | United States |
| Company sponsor | Nationwide Children's Hospital |
| Other ID(s) | AutoCAR19 |
| Cohort 1 | |||||||||||||
|
|||||||||||||